Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06308562 · ClinicalTrials.gov registry record · NA

Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease

A NA study of Peripheral Arterial Disease, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06308562 is a NA study of Peripheral Arterial Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06308562, a NA study of Peripheral Arterial Disease, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine if using Fuzzy Wale compression stockinet can assist in reducing the healing time and decrease costs in transtibial amputation patients as compared to standard of care treatment compression stocking.

Interventions

  • DEVICE Fuzzy Wale Compression Stockinet

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-07-07
Est. Completion 2026-12-31
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT06308562

The ClinicalTrials.gov registry entry for NCT06308562 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,206-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Fuzzy Wale Compression Stockinet is the first listed.

NCT06308562 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06308562 about?

NCT06308562 is a clinical study titled "Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease". The objective of this study is to determine if using Fuzzy Wale compression stockinet can assist in reducing the healing time and decrease costs in transtibial amputation patients as compared to standard of care treatment compression stocking.

What is the current status of trial NCT06308562?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-07. Estimated completion is 2026-12-31.

What conditions does trial NCT06308562 study?

This clinical trial studies the following conditions: Peripheral Arterial Disease.

What interventions are being tested in trial NCT06308562?

The interventions under investigation include: Fuzzy Wale Compression Stockinet (DEVICE).

Who is sponsoring clinical trial NCT06308562?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06308562 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Peripheral Arterial Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.